Both in Pharmaceuticals
Rani Therapeutics Holdings vs Spero Therapeutics
Over the past year RANI returned −59.3% and SPRO returned −55.1%; their daily moves had a correlation of 0.13.
RANI −59.3% SPRO −55.1%Growth of $1, one year, split-adjusted
| Metric | RANI | SPRO |
|---|---|---|
| Price | $0.5900 | $1.06 |
| Market cap | $68.1M | $61.7M |
| Today | −2.54% | −4.50% |
| 1 month | −25.8% | −15.9% |
| 6 months | −37.2% | −57.3% |
| Year to date | −56.3% | −54.5% |
| 1 year | −64.5% | −54.5% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −432.7% | — |
| P/E (TTM) | — | 8.4× |
| Price / sales | 14.0× | 1.3× |
| Net cash | $53.4M | $50.7M |
| Dividend yield | — | — |
| Volatility (60d) | 62.1% | 58.8% |
| Short % of float | 10.4% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).